CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
Proton Radiation Plan +2 moreradiation
Likely dose
21-39.6 Gy/CGE to the planning target volume via proton, photon, or IMRT radiationAI-extracted
Key inclusion· 2
  • ✓Confirmed classic Hodgkin lymphoma
  • ✓Completed chemotherapy
Key exclusion· 2
  • ✕Prior radiotherapy
  • ✕Prior or concurrent cancer (except non-melanomatous skin cancer)

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00850200
NCT00850200N/ACompleted
CompareCT.gov

Improving the Therapeutic Ratio by Using Proton Beam Radiation Therapy for Patients With Stage IA-IIIBX (Bulky/Non-bulky) Hodgkin Lymphoma Involving the Mediastinum Following Standard Chemotherapy

University of Florida·interventional·Posted Feb 24, 2009·Updated Jan 31, 2019

In Brief

A clinical study evaluating Proton Radiation Plan, Conventional Photon Radiation Plan, and 1 other intervention for Hodgkin Lymphoma. Completed, enrolled 20 participants across 1 site.

Detailed Summary

The purpose of this study is to reduce the risk of radiation related side effects and complications by treating with radiation (protons or photons) that exposes less of normal organs to low dose radiation.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHodgkin Lymphoma
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 24, 2009
Enrollment StartAug 1, 2009
Primary CompletionMay 1, 2013
Study CompletionJan 9, 2018
TodayJul 2, 2026
Enrollment to primary: 3.8 yearsPosted 17.4 years ago

Interventions

Proton Radiation Planradiation

Between 21-39.6 Gy/CGE to the PTV

Conventional Photon Radiation Planradiation

Between 21-39.6 Gy/CGE to the PTV

Intensity Modulated Radiation Planradiation

Between 21-39.6 Gy/CGE to the PTV